Both in Pharmaceuticals
Foghorn Therapeutics vs Yarrow Bioscience
Over the past year FHTX returned −49.9% and YARW returned −42.5%; their daily moves had a correlation of 0.07.
FHTX −49.9% YARW −42.5%Growth of $1, one year, split-adjusted
| Metric | FHTX | YARW |
|---|---|---|
| Price | $2.22 | $15.53 |
| Market cap | $131.5M | $131.1M |
| Today | +3.99% | −15.46% |
| 1 month | +12.4% | −17.1% |
| 6 months | −52.7% | — |
| Year to date | −59.0% | — |
| 1 year | −47.4% | — |
| Revenue growth (YoY) | +112.7% | — |
| Gross margin | 100.0% | — |
| Net margin | −44.7% | — |
| P/E (TTM) | — | — |
| Price / sales | 3.6× | — |
| Net cash | $167.6M | — |
| Dividend yield | — | — |
| Volatility (60d) | 98.7% | — |
| Short % of float | 7.3% | 2.0% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).